Condition: Moderate to Severe Glabellar Lines · Sponsor: Ipsen
The purpose of this study is to assess the effectiveness and safety of Corabotase (also known as IPN10200) compared to placebo in the improvement of the appearance of moderate to severe glabellar lines in adult participants. Glabellar lines are wrinkle-like lines that appear between the eyebrows and can become more noticeable with age or repeated facial expressions. They may affect a person's appearance and confidence. In this study, all participants will receive a single injection of either Corabotase or placebo (the study drug). There will be 3 periods in this study: * A screening period (up to 20 days) to assess whether the participant can take part, requiring at least 1 visit to the study centre. * A treatment period (Day 1) where all the eligible participants will receive a single injection of IPN10200 or placebo. * A follow-up period (52 weeks) where participants' health will be monitored, consisting of regular visits to the study centre and 1 telephone call visit. Participants will undergo health measurements and observation, including blood sampling, physical examinations, clinical evaluations and electrocardiograms (ECG: recording of the electrical activity of heart). They will also be asked to fill in questionnaires and keep a diary. Each participant will be in this study for up to 55 weeks. Participants may withdraw consent to participate at any time.
This description comes directly from the study's public registry record.
Ipsen Recruitment Enquiries · see email · clinical.trials@ipsen.com
Always discuss trial participation with your own doctor first.
| Skin Wellness Dermatology - Homewood | Birmingham, Alabama, United States | Recruiting |
| Advanced Research Associates | Glendale, Arizona, United States | Recruiting |
| Avacare | Scottsdale, Arizona, United States | Not Yet Recruiting |
| Investigate MD, LLC | Scottsdale, Arizona, United States | Recruiting |
| Ablon Skin Institute and Research Center | Manhattan Beach, California, United States | Recruiting |
| Keith A. Marcus, MD Inc | Redondo Beach, California, United States | Recruiting |
| West Dermatology | San Diego, California, United States | Not Yet Recruiting |
| Ava T. Shamban, M.D., Inc. | Santa Monica, California, United States | Recruiting |
| Art of Skin MD | Solana Beach, California, United States | Recruiting |
| Pacific Clinical Innovations Inc. | Vista, California, United States | Recruiting |
| Skin Research Institute | Coral Gables, Florida, United States | Recruiting |
| ICON Dermatology and Aesthetics | Bethesda, Maryland, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07427797